Correlation of c-erbB-2, EGF and EGFR expression with postoperative survival of patients with advanced carcinoma of the stomach.
暂无分享,去创建一个
A. Kemona | Andrzej Kemona | Jolanta Czyzewska | Katarzyna Guzinska-Ustymowicz | J. Czyżewska | K. Guzińska-ustyMowiCz
[1] H. Hoefler,et al. The use of molecular biology in diagnosis and prognosis of gastric cancer. , 2000, Surgical oncology.
[2] M. Manns,et al. Regulation of gastric epithelial cell growth by Helicobacter pylori: offdence for a major role of apoptosis. , 1997, Gastroenterology.
[3] W. Coyle,et al. Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor , 1999, American Journal of Gastroenterology.
[4] Atsushi Ochiai,et al. Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma , 1988, International journal of cancer.
[5] A. Dursun,et al. Expression of c-erbB-2 Oncoprotein in Gastric Carcinoma: Correlation with Histopathologic Characteristics and Analysis of Ki-67 , 1999, Pathology & Oncology Research.
[6] H. Höfler,et al. Gastric adenocarcinoma: pathomorphology and molecular pathology , 2001, Journal of Cancer Research and Clinical Oncology.
[7] M. Vasei,et al. The expression of c-erbB-1 and c-erbB-2 in Iranian patients with gastric carcinoma , 2009, Pathology Oncology Research.
[8] M. Ruge,et al. Impact of epidermal growth factor (EGF) radioreceptor analysis on long-term survival of gastric cancer patients. , 2002, Anticancer research.
[9] I. Biunno,et al. Expression of the epidermal growth factor receptor gene in human intestinal metaplasia: a preliminary report. , 1997, Scandinavian journal of gastroenterology.
[10] T. Mitsudomi,et al. Serum level and tissue expression of c-erbB-2 protein in lung adenocarcinoma. , 1995, Chest.
[11] R. Nicholson,et al. EGFR and cancer prognosis. , 2001, European journal of cancer.
[12] H. P. Wang,et al. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer. , 1997, Hepato-gastroenterology.
[13] G. Carpenter. Receptor tyrosine kinase substrates: src homology domains and signal transduction , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] J. V. van Sandick,et al. Prognostic Value of Laurén Classification and c-erbB-2 Oncogene Overexpression in Adenocarcinoma of the Esophagus and Gastroesophageal Junction , 1999, Annals of Surgical Oncology.
[15] Yao-zong Yuan,et al. Effects of epidermal growth factor on the growth of human gastric cancer cell and the implanted tumor of nude mice. , 2002, World journal of gastroenterology.
[16] N. Normanno,et al. Epidermal growth factor-related peptides and their receptors in human malignancies. , 1995, Critical reviews in oncology/hematology.
[17] J. Furui,et al. erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection. , 1994, Surgery.
[18] John Mendelsohn,et al. The EGF receptor family as targets for cancer therapy , 2000, Oncogene.
[19] H. P. Wang,et al. Overexpression of mutant p53 and c‐erbB‐2 proteins and mutations of the p15 and p16 genes in human gastric carcinoma: With respect to histological subtypes and stages , 1998, Journal of gastroenterology and hepatology.
[20] R. Playford,et al. Why is epidermal growth factor present in the gut lumen? , 1996, Gut.
[21] Y. Yarden,et al. Advances in Brief Tumor-inhibitory Antibodies to HER-2 / ErbB2 May Act by Recruiting c-Cbl and Enhancing Ubiquitination of HER-21 , 2000 .
[22] Hiroshi Yamamoto,et al. Amplification of the c-met, c-erbB-2 and Epidermal Growth Factor Receptor Gene in Human Gastric Cancers: Correlation to Clinical Features , 1998, Oncology.
[23] H. Allgayer,et al. c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] C. Messa. Epidermal Growth Factor and 17ß-Estradiol Effects on Proliferation of a Human Gastric Cancer Cell Line (AGS) , 2000, Scandinavian journal of gastroenterology.
[25] C. Cordon-Cardo,et al. Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. , 1990, Oncogene.
[26] B. Groner,et al. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. , 1988, Cancer research.
[27] N. Nomura,et al. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor , 1986, Nature.
[28] T. Okuda,et al. Clinical significance of epidermal growth factor (EGF), EGF receptor, and c‐erbb‐2 in human gastric cancer , 1995, Cancer.
[29] C. la Vecchia,et al. Trends of cancer mortality in Europe, 1955-1989: I, Digestive sites. , 1992, European journal of cancer.
[30] H. Tsuda,et al. Combined measurement of the c‐erbb‐2 protein in breast carcinoma tissues and sera is useful as a sensitive tumor marker for monitoring tumor relapse , 2000, International journal of cancer.
[31] S. Gurel,et al. The Relationship between c-erbB-2 Oncogene Expression and Clinicopathological Factors in Gastric Cancer , 1999, The Journal of international medical research.
[32] K. Choe,et al. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer. , 2003, Japanese journal of clinical oncology.
[33] T. Hirao,et al. The prognostic significance of amplification and overexpression of c‐met and c‐erb B‐2 in human gastric carcinomas , 1999, Cancer.
[34] L. David,et al. c-erb B-2 Expression Is Associated with Tumor Location and Venous Invasion and Influences Survival of Patients with Gastric Carcinoma , 2002, International journal of surgical pathology.
[35] K. Syrigos,et al. Clinical significance of soluble c-erbB-2 levels in the serum and urine of patients with gastric cancer. , 2002, Anticancer research.
[36] Y. Shiratori,et al. Activation of epidermal growth factor receptor kinase in gastric carcinoma: a preliminary study , 2000, American Journal of Gastroenterology.
[37] H. Yazici,et al. Utility of c-crbB-2 Expression in Tissue and Sera of Ovarian Cancer Patients , 2000, Cancer investigation.
[38] E. Wynder,et al. The decline in gastric cancer: epidemiology of an unplanned triumph. , 1986, Epidemiologic reviews.
[39] J. Nährig,et al. Epidermal growth factor receptor expression correlates with poor survival in gastric adenocarcinoma from Mexican patients: a multivariate analysis using a standardized immunohistochemical detection system , 2004, Modern Pathology.
[40] Shenhua Xu,et al. Study on the relationship between P-glycoprotein (P-gp) and C-erbB-2 expression in gastric carcinoma , 2007 .
[41] Y. Maehara,et al. c-erbB-2 expression is predictive for lymphatic spread of clinical gastric carcinoma. , 1997, Hepato-gastroenterology.